• Hikma, GSK stop talks over potential buyout deal of Egypt, Tunisia assets expresspharma
    March 12, 2021
    Hikma Pharmaceuticals and GlaxoSmithKline have ended talks over a potential buyout deal for the latter’s pharma, consumer commercialisation and manufacturing business in Egypt and its drugs business in Tunisia, the companies said.
  • Hikma intends to acquire assets in Egypt, Tunisia expresspharma
    January 27, 2021
PharmaSources Customer Service